3 items
Calculate indicative Mesoblast (MSB) price on ASX equivalent price from MESO (NASDAQ) and AUD/USD exchange rate data. Calculates indicative MSB (ASX) equivalent price from MESO (NASDAQ) and AUD/USD market data. Mesoblast is an Australian regenerative medicine and biopharmaceutical company focused on developing allogeneic (off-the-shelf) cellular medicines. Their therapies, derived from mesenchymal stem cells (MSCs) extracted from adult bone marrow, are designed to treat severe and life-threatening inflammatory conditions, cardiovascular diseases, and orthopedic disorders.
rating_count is the Chrome Web Store ratings count, not a written-review count.